Navigation Links
Defined Health Announces Final Speaker Roster and Agenda for Therapeutic Insight 2008
Date:4/9/2008

FLORHAM PARK, N.J., April 9 /PRNewswire/ -- Defined Health has announced the final agenda and speaker list for its 8th annual Therapeutic Insight conference. Therapeutic Insight 2008 ("TI2008") will take place on April 28 - 30, 2008, at The Westin New York at Times Square. The following industry decision-makers and key opinion leaders will discuss relevant pharma/biotech issues and current trends in oncology, cardiovascular disease, neuropsychiatric disorders, antimicrobials, therapeutic vaccines and orphan diseases:

* Professor Ruth Arnon, The Paul Ehrlich Professor of Immunology,

Weizmann Institute of Science

* Charles Baum, MD, PhD, Vice President, Global R&D, Oncology, Pfizer

* Karen Bernstein, PhD, Chairman and Editor-in-Chief, BioCentury

* Thomas P. Blackburn, PhD, DSc, TPBioVentures LLC

* Jeffrey M. Bockman, PhD, Vice President, Defined Health

* Michael R. Bristow, MD, PhD, Founder, Chairman and Chief Science and

Medical Officer, ARCA Discovery

* Leslie J. Browne, PhD, President & CEO, Pharmacopeia Inc.

* Shannon Brownlee, Schwartz Senior Fellow, New American Foundation

* Michael D. Clayman, MD, CEO, Flexion Therapeutics

* Earl M. (Duke) Collier, Jr., JD, Executive Vice President, Genzyme

Corporation

* Albert R. Collinson, PhD, Chief Business Officer, Rib-X Pharmaceuticals

* Lode Debrabandere, PhD, Vice President & General Manager Inflammatory

Diseases, Osiris

* Mark W. Frohlich, MD, Senior VP & Chief Medical Officer, Dendreon

Corporation

* Matthew Gantz, Chief Executive Officer & Founder, Acureon Pharma

* Milton H. Grannatt, PhD, Vice President and Head, Negotiations, New

Growth Opportunities, Global Business Development & Licensing, Novartis

Pharmaceuticals Corporation

* Russell Hagan, PhD, Senior Vice President, Head of Research &

Development, BTG International

* Roger J. Hajjar, MD, Director, Cardiovascular Research Center, Mt.

Sinai School of Medicine, Arthur & Janet C. Ross Professor of Medicine,

Co-founder Celladon Corporation, Co-founder Nanocor Inc.

* Steven J. Heller, Global Marketing Leader, Oncology New Product

Development and Early Commercial Input, Johnson & Johnson Worldwide

Strategic Marketing

* Professor Jutta Heim, PhD, Chief Scientific Officer, Basilea

Pharmaceutica

* Claudia Hirawat, SVP Corporate Development, PTC Therapeutics

* Ginger S. Johnson, PhD, Vice President, Defined Health

* Matthew W. Kalnik, PhD, VP, Business Development & Project Management,

Nabi Biopharmaceuticals

* Jeremy Levin, PhD, Senior Vice President, External Science, Technology

and Licensing, Bristol-Myers Squibb

* Christopher Lipinski, PhD, Scientific Advisor, Melior Discovery

* Joseph S. McCracken, DVM, Vice President, Business & Commercial

Development, Genentech

* David P. Meeker, MD, President, LSD Therapeutics, Genzyme

* Eszter Nagy, MD, PhD, Vice President, Pre-clinical R&D, Intercell

* Steve J. Offord, PhD, Vice President CNS New Products Marketing, Market

Access and Business Development, sanofi-aventis

* Carlos Plata-Salaman, DSc, MD, Head, Global External Research &

Development, Eli Lilly & Co.

* Edward C. Saltzman, President, Defined Health

* Deborah Schrag, MD, Associate Professor of Medicine, Dana-Farber Cancer

Institute

* Mark J. Simon, President, Williver Group LLC

* Greg Wiederrecht, PhD, Vice President & Head, External Scientific

Affairs, Merck & Co.

* Daphne Zohar, Founder & Managing Partner, PureTech Ventures

The final agenda, list of speakers and registration information along with content and attendee statistics from prior Therapeutic Insight conferences is available on the conference website, http://www.therapeuticinsight.com.

Shannon Brownlee, Schwartz Senior Fellow at the New America Foundation, will present a keynote address at TI2008 entitled, "Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer." Her book of the same title was named the best economics book of 2007 by the New York Times. Ms. Brownlee's speaking fee will be donated to charity.

The 2+ day conference will include two networking events, with additional opportunities for interaction throughout the event. The conference will begin on Tuesday morning, April 29, with a plenary presentation by Ed Saltzman, President of Defined Health, entitled: "Surviving, Sustaining and Succeeding in the Pursuit of Innovation."

Therapeutic Insight 2008 is presented by Defined Health and Communitech Market Intelligence, with a sponsorship from JNK Securities. To register, or for more information, please visit http://www.therapeuticinsight.com, or contact Communitech: (914) 245-7764, http://www.cmius.com, or Defined Health: (973) 292-5001, http://www.definedhealth.com.

Contact:

Ginny E. Llobell

Vice President

Defined Health

973-292-5001 X 235


'/>"/>
SOURCE Defined Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sensitivity of brain center for sound space defined
2. Pathway to cell death redefined in landmark study
3. Pathway to cell death redefined in landmark study
4. John Hancock Launches Defined Benefit Program
5. New upper limit defined for normal ALT in adolescent males
6. Shannon Brownlee, Author of Overtreated, to Keynote at Defined Healths 8th Annual Therapeutic Insight Conference
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Air pollution linked to cardiovascular risk indices in healthy young adults
10. More proof needed of safety and quality of electronic personal health records
11. Health care incentive model offers collaborative approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: